Works by Wadsak, Wolfgang
Results: 148
Intramolecular Friedel‐Crafts Acylation of [<sup>11</sup>C]Isocyanates Enabling the Radiolabeling of [carbonyl‐<sup>11</sup>C]DPQ.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 28, p. 1, doi. 10.1002/chem.202400581
- By:
- Publication type:
- Article
Response assessment using [<sup>68</sup>Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2020, v. 80, n. 1, p. 74, doi. 10.1002/pros.23919
- By:
- Publication type:
- Article
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.
- Published in:
- Frontiers in Human Neuroscience, 2017, v. 11, p. 1, doi. 10.3389/fnhum.2017.00048
- By:
- Publication type:
- Article
Reproducibility of Quantitative Brain Imaging Using a PET-Only and a Combined PET/MR System.
- Published in:
- Frontiers in Neuroscience, 2017, p. 1, doi. 10.3389/fnins.2017.00396
- By:
- Publication type:
- Article
Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain.
- Published in:
- World Journal of Biological Psychiatry, 2012, v. 13, n. 6, p. 413, doi. 10.3109/15622975.2011.630405
- By:
- Publication type:
- Article
Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [<sup>18</sup> F]FDG-PET imaging. Is it of value in asymptomatic patients?
- Published in:
- 2018
- By:
- Publication type:
- journal article
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01542-8
- By:
- Publication type:
- Article
PIK3CA Mutational Status Is Associated with High Glycolytic Activity in ER+/HER2- Early Invasive Breast Cancer: a Molecular Imaging Study Using [<sup>18</sup>F]FDG PET/CT.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [<sup>18</sup>F]FE@SNAP and [<sup>11</sup>C]SNAP-7941.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity.
- Published in:
- Brain Structure & Function, 2018, v. 223, n. 3, p. 1369, doi. 10.1007/s00429-017-1558-0
- By:
- Publication type:
- Article
Impact of COMT genotype on serotonin-1A receptor binding investigated with PET.
- Published in:
- Brain Structure & Function, 2014, v. 219, n. 6, p. 2017, doi. 10.1007/s00429-013-0621-8
- By:
- Publication type:
- Article
Cerebral serotonin transporter asymmetry in females, males and male-to-female transsexuals measured by PET in vivo.
- Published in:
- Brain Structure & Function, 2014, v. 219, n. 1, p. 171, doi. 10.1007/s00429-012-0492-4
- By:
- Publication type:
- Article
The QuADRANT study: current status and recommendations for improving uptake and implementation of clinical audit of medical radiological procedures in Europe—the nuclear medicine perspective.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 9, p. 2576, doi. 10.1007/s00259-023-06203-6
- By:
- Publication type:
- Article
Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 50, n. 1, p. 1, doi. 10.1007/s00259-022-06011-4
- By:
- Publication type:
- Article
2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3309, doi. 10.1007/s00259-022-05881-y
- By:
- Publication type:
- Article
EANM position on the in-house preparation of radiopharmaceuticals.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1650, doi. 10.1007/s00259-020-05082-5
- By:
- Publication type:
- Article
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 3, p. 713, doi. 10.1007/s00259-019-04584-1
- By:
- Publication type:
- Article
Prospective evaluation of the performance of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 10, p. 2169, doi. 10.1007/s00259-019-04361-0
- By:
- Publication type:
- Article
[<sup>68</sup>Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 8, p. 1616, doi. 10.1007/s00259-019-04322-7
- By:
- Publication type:
- Article
Response assessment using <sup>68</sup>Ga-PSMA ligand PET in patients undergoing <sup>177</sup>Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 5, p. 1063, doi. 10.1007/s00259-018-4236-4
- By:
- Publication type:
- Article
[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 4, p. 558, doi. 10.1007/s00259-017-3831-0
- By:
- Publication type:
- Article
The value of [C]-acetate PET and [F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1732, doi. 10.1007/s00259-017-3724-2
- By:
- Publication type:
- Article
**-Postprandial pancreatic [C]methionine uptake after pancreaticoduodenectomy mirrors basal beta cell function and insulin release.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 3, p. 509, doi. 10.1007/s00259-016-3451-0
- By:
- Publication type:
- Article
Quantitative assessment of atherosclerotic plaques on F-FDG PET/MRI: comparison with a PET/CT hybrid system.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 8, p. 1503, doi. 10.1007/s00259-016-3308-6
- By:
- Publication type:
- Article
Erratum to: Quantitative assessment of atherosclerotic plaques on F-FDG PET/MRI: comparison with a PET/CT hybrid system.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
[F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 5, p. 741, doi. 10.1007/s00259-014-2976-3
- By:
- Publication type:
- Article
Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. 1, doi. 10.1186/s41181-019-0083-2
- By:
- Publication type:
- Article
Comparison of fully-automated radiosyntheses of [<sup>11</sup>C]erlotinib for preclinical and clinical use starting from in target produced [<sup>11</sup>C]CO<sub>2</sub> or [<sup>11</sup>C]CH<sub>4</sub>.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0044-1
- By:
- Publication type:
- Article
Task-evoked metabolic demands of the posteromedial default mode network are shaped by dorsal attention and frontoparietal control networks.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.84683
- By:
- Publication type:
- Article
Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT<sub>1A</sub> Receptor by Combining In Vivo PET and Allen Human Brain Atlas Data.
- Published in:
- Cerebral Cortex, 2020, v. 30, n. 6, p. 3771, doi. 10.1093/cercor/bhz341
- By:
- Publication type:
- Article
Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo.
- Published in:
- Cerebral Cortex, 2019, v. 29, n. 1, p. 372, doi. 10.1093/cercor/bhy249
- By:
- Publication type:
- Article
Multimodal [<sup>18</sup>F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic Mice.
- Published in:
- Journal of Bone & Mineral Research, 2019, v. 34, n. 9, p. 1632, doi. 10.1002/jbmr.3748
- By:
- Publication type:
- Article
Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 986, doi. 10.2967/jnumed.123.265603
- By:
- Publication type:
- Article
First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-<sup>11</sup>C-Me-NB1.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262427
- By:
- Publication type:
- Article
A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-<sup>11</sup>C-Me-NB1.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262427
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)- <sup>11</sup>C-Me-NB1.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262427
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 4, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article